Previous close | 3.7000 |
Open | 0.0000 |
Bid | 1.3000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.0000 - 0.0000 |
52-week range | |
Volume | |
Avg. volume | 1,288,952 |
Market cap | 3.136M |
Beta (5Y monthly) | 0.69 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0500 |
Earnings date | 24 May 2024 - 28 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 0.43 |
Featured Company at Respiratory Innovation Summit to Jump Start Robust PresenceDURHAM, NC and LONDON, May 08, 2024 (GLOBE NEWSWIRE) -- Polarean (AIM: POLX), a commercial-stage medical device leader in advanced magnetic resonance imaging (MRI) of the lungs, has been selected as one of the featured companies and a poster presenter at the American Thoracic Society’s (ATS) 2024 Respiratory Innovation Summit (RIS), a testament to the value of our XENOVIEW technology seen across lung clinicians and pu
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...